Medifast, Inc. MED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.51M | -3.10M | -2.12M | -18.12M | -2.26M |
| Total Depreciation and Amortization | 2.36M | 3.45M | 3.48M | 3.47M | 3.45M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.01M | 2.82M | 812.00K | 15.65M | 1.86M |
| Change in Net Operating Assets | 4.43M | -1.47M | -1.91M | -6.28M | 9.07M |
| Cash from Operations | 3.30M | 1.70M | 260.00K | -5.28M | 12.11M |
| Capital Expenditure | -427.00K | -969.00K | -1.10M | -1.35M | -1.36M |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 3.64M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.40M | -264.00K | -19.67M | -3.60M | -12.92M |
| Cash from Investing | -16.82M | -1.23M | -17.13M | -4.95M | -14.28M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 1.00K | -- |
| Repurchase of Common Stock | -11.00K | 0.00 | -814.00K | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -83.00K | -87.00K | 0.00 | 0.00 |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -11.00K | -83.00K | -901.00K | 1.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | 4.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.54M | 381.00K | -17.77M | -10.22M | -2.17M |